The effectiveness of a pour-on formulation of novaluron (Novatack Pour-on 5% Al, Clarion Biociencias LTDA, Goiania, Brazil), a benzoylphenyl urea acaricide, was evaluated by applying a low and high concentrations (1 mg/20 kg body weight and 1 mg/10 kg body weight) to cattle infested with all parasitic developmental stages (adults, nymphs, and larvae) of Rhipicephalus (Boophilus) microplus (Canestrini). The therapeutic percentage reduction in the number of females that reached repletion following treatment was 24.8 and 24.6% for the low and high rates, respectively. No difference in the weight of engorged females recovered from treated calves or in the index of fecundity (IF) was observed for either rate in comparison with the untreated control, and no significant difference in the overall therapeutic level of control was observed between the low and the high rates. Results obtained from the analysis of persistent (residual) efficacy of both rates showed no significant differences between the treatments at weekly intervals; however, the percent control of the IF observed against larvae infested 1 and 2 wks after treatment of both rates was moderate indicating that novaluron appears to be more effective against larvae that come into contact with cattle after treatment than against adults or nymphs already infesting the animal at the time of treatment.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 47 • No. 3